Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB-Reference-Cited by-同舟云学术

Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB

Published:2021-01 Issue: Volume:534 Page:902-907
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Zhu Jingjing^ORCID,Zhang Ying^ORCID,Chen Xiaojie^ORCID,Zhang Yue^ORCID,Zhang Ke^ORCID,Zheng Hongyue,Wei Yinghui,Zheng Hangsheng,Zhu Jiazhen,Wu Fang,Piao Ji-Gang,Zhu Zhihong,Li Fanzhu^ORCID

Funder

National Natural Science Foundation of China

Zhejiang Chinese Medical University School-level Scientific Research Fund Project

Natural Science Founfation of Zhejiang Province

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference38 articles.

1. Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma;Nowosielski;Neurology,2014

2. The epidemiology of glioma in adults: a "state of the science" review;Ostrom;Neuro Oncol.,2014

3. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors;Bhujbal;Adv. Drug Deliv. Rev.,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted therapeutical role of low‐density lipoprotein receptor family in high‐grade glioma;Molecular Oncology;2024-09-14

2. Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment;Biomedicines;2024-08-11

3. Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor;Indian Journal of Microbiology;2024-06-21

4. Sustainable Approaches in Green Synthesis of Silica Nanoparticles Using Extracts of Chlorella and Its Application;Applied Biochemistry and Biotechnology;2024-04-25

5. Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles;Journal of Drug Delivery Science and Technology;2024-04